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Introduction
Natural killer cells are of particular
interest during pregnancy, as they
account for 70% of all lymphocytes in the
placenta¹. Thus, abnormalities in natural
killer (NK) cells have been implicated in
pre-term birth, the leading cause of
infant mortality². A suggested causative
factor is a deletion at nucleotide 1597 in
the HLA-G gene, which codes for the
HLA-G histocompatibility antigen. HLA-G
is of interest as: it is a rare “non-classical”
antigen predominantly produced by fetal
cells³, and HLA-G polymorphisms have Figure 1. Premature baby in Neonatal Intensive
Care Unit
been implicated in another pregnancy
disorder: preeclampsia⁴. The interaction between HLA-G antigen on trophoblasts
and inhibitory killer-immunoglobulin like receptor (KIR) 2DL4 on natural killer cells
produces an inhibitory effect on the natural killer cell³.

Maternal DNA was amplified using quantitative (“real-time”) PCR (qPCR), which
can quantify target sequences of DNA. Each sample was run twice with primers
positive (1597∆C) and negative (HLA-G, or 1597) for the deletion. Peaks at
approx. 88°C signified the deletion, and peaks at 77 °C (with absence of a
positive peak) signified absence of the deletion.
Figure 3. qPCR peaks positive
and negative for deletion,
respectively. The reaction is run
with a dye that causes PCR
products to fluoresce. During
the melt stage, fluorescence is
lost as DNA strands
disassociate. Loss of
fluorescence occurs at a unique
temperature depending on
whether or not the deletion is
present.

Results were confirmed using gel electrophoresis.
Figure 4. Maternal DNA that has
been amplified with the 1597∆C
primer.

Results

Figure 2. Interaction of HLA-G and KIR 2DLA between trophoblast and NK cells.

However, a deletion at nucleotide 1597 produces a frameshift mutation, rendering
the HLA-G antigen unable to interact with KIR 2DL4⁵. It is speculated that this
failed interaction might cause the mother’s immune system to allow an increased
natural killer cell response to the fetus, aborting the pregnancy. Here we examine
the DNA from a large population of African-American mothers to determine if this
association between HLA-G 1597∆C is causative in pre-term birth. The AfricanAmerican population is of particular interest as this demographic has a uniquely
high incidence of preterm birth.

GAACGAGGACCTGCGCTCC
Figure 3. HLA-G 1597∆C deletion site.

Materials & Methods
Samples are from African-American mothers who gave birth between Jan. 2000
and Apr. 2007 (California Very Preterm Birth Study)²: 343 controls, 78
preeclampsia, 330 pre-term (pre-term defined as birth at <34 weeks).

Genotype

Normal
C/C

Deletion
∆/C

Deletion
∆/∆

Individuals

630

81

2

Frequency

88.36%

11.36%

0.28%

Conclusion
We are confirming the association between 1597∆C and pre-term birth in this
population, and a positive association would suggest that mothers possessing the
deletion are at risk for delivering pre-term. As this is a double-blind study, we are
unaware which genotypes correlate with pre-term birth. We are currently awaiting
completion of the statistical analysis by the California Department of Health.
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